Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES Fact Sheet  (INDOCO)



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF


Here is the latest financial fact sheet of INDOCO REMEDIES. For more details, see the INDOCO REMEDIES quarterly results and INDOCO REMEDIES share price. For a sector overview, read our pharmaceuticals sector report.

INDOCO REMEDIES Price History

Price Rs 332.5
Mkt Cap Rs m 30,646
Vol '000 7.2
P/E X 30.4
P/CF X 14.4
EPS (TTM) Rs 10.9
1 Day % -0.1
No. of shares m 92.18
1 Week % -4.4
1 Month % 0.8
1 Year % 2.1
52 week H/L Rs 417.0/307.0
As on Apr 18, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

INDOCO REMEDIES Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
INDOCO REMEDIES EQUITY SHARE DATA
High Rs238272336530423 
Low Rs150133190285308 
Sales per share (Unadj.) Rs105.1120.1134.7167.2181.1 
Earnings per share (Unadj.) Rs-0.32.610.116.815.4 
Diluted earnings per shareRs-0.32.610.116.815.4 
Cash flow per share (Unadj.) Rs7.510.318.025.423.1 
Dividends per share (Unadj.) Rs0.300.301.502.252.25 
Adj. dividends per shareRs0.300.301.502.252.25 
Avg Dividend yield %0.20.10.60.60.6 
Book value per share (Unadj.) Rs71.773.783.498.2111.5 
Adj. book value per shareRs71.773.783.498.1111.5 
Shares outstanding (eoy) m92.1592.1592.1592.1592.15 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.81.72.02.42.0 
Avg P/E ratio x-616.077.526.024.323.7 
P/CF ratio (eoy) x26.119.714.616.115.8 
Price / Book Value ratio x2.72.73.14.13.3 
Dividend payout %-95.211.514.913.414.6 
Avg Mkt Cap Rs m17,88918,68324,21537,54033,683 
No. of employees `000NANANANANA 
Total wages/salary Rs m2,3172,5652,7402,9633,226 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
INDOCO REMEDIES INCOME DATA
Net Sales Rs m9,68411,06612,41515,40816,686 
Other income Rs m6748913424 
Total revenues Rs m9,75111,11412,50615,44216,710 
Gross profit Rs m7661,2082,1833,2632,860 
Depreciation Rs m716708731790706 
Interest Rs m211263223141250 
Profit before tax Rs m-932861,3202,3661,928 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-6445390818505 
Profit after tax Rs m-292419301,5481,423 
Gross profit margin %7.910.917.621.217.1 
Effective tax rate %68.815.629.534.626.2 
Net profit margin %-0.32.27.510.08.5 
INDOCO REMEDIES BALANCE SHEET DATA
Current assets Rs m5,3815,6316,2258,6698,082 
Current liabilities Rs m4,4554,5904,0695,1824,245 
Net working cap to sales %9.69.417.422.623.0 
Current ratio x1.21.21.51.71.9 
Inventory Days Days121222825 
Debtors Days Days738693687704768 
Net fixed assets Rs m6,8456,7647,1177,1259,055 
Share capital Rs m184184184184184 
"Free" reserves Rs m6,4226,6117,5068,86210,092 
Net worth Rs m6,6066,7967,6909,04610,276 
Long term debt Rs m1,2879699699591,435 
Total assets Rs m12,22512,39613,34315,79417,137 
Interest coverage x0.62.16.917.78.7 
Debt to equity ratio x0.20.10.10.10.1 
Sales to assets ratio x0.80.90.91.01.0 
Return on assets %1.54.18.610.79.8 
Return on equity %-0.43.512.117.113.8 
Return on capital %1.57.117.825.118.6 
Exports to sales %29.532.043.742.647.5 
Imports to sales %11.210.710.210.511.5 
Exports (fob) Rs m2,8583,5435,4266,5657,919 
Imports (cif) Rs m1,0851,1871,2701,6131,917 
Fx inflow Rs m2,8583,5435,4266,5657,919 
Fx outflow Rs m1,0851,1871,2701,6131,917 
Net fx Rs m1,7732,3574,1574,9526,002 
INDOCO REMEDIES CASH FLOW
From Operations Rs m 1,321 1,228 822 1,738 1,788 
From Investments Rs m -1,038 -559 -667 -1,214 -2,082 
From Financial Activity Rs m -161 -639 -299 -444 228 
Net Cashflow Rs m 122 30 -143 80 -65 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 58.7%
Institution 21.3%
Non-Institution 20.0%
Total 100.0%
Free Float 41.3%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2023
 

Company Information

Regd Off Indoco House, 166 C S T Road, Kalina Santacruz (East), Mumbai - 400098
E-mail compliance.officer@indoco.com Web www.indoco.com
Tel 022-62871000 / 68791250 Fax 022-26520787
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
Auditor Patkar & Pendse
CHM: Suresh G Kare COMP SEC: Jayshankar Menon YEAR OF INC: 1947 BSE CODE: 532612 FV (Rs): 2 DIV YIELD (%): 0.7

Read: INDOCO REMEDIES 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare INDOCO REMEDIES With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.